GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (BOM:533543) » Definitions » Days Sales Outstanding

Brooks Laboratories (BOM:533543) Days Sales Outstanding : 84.01 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories Days Sales Outstanding?

Brooks Laboratories's average Accounts Receivable for the three months ended in Mar. 2024 was ₹163.2 Mil. Brooks Laboratories's Revenue for the three months ended in Mar. 2024 was ₹177.2 Mil. Hence, Brooks Laboratories's Days Sales Outstanding for the three months ended in Mar. 2024 was 84.01.

The historical rank and industry rank for Brooks Laboratories's Days Sales Outstanding or its related term are showing as below:

BOM:533543' s Days Sales Outstanding Range Over the Past 10 Years
Min: 63.53   Med: 71.43   Max: 91.9
Current: 85.49

During the past 13 years, Brooks Laboratories's highest Days Sales Outstanding was 91.90. The lowest was 63.53. And the median was 71.43.

BOM:533543's Days Sales Outstanding is ranked worse than
63.59% of 997 companies
in the Drug Manufacturers industry
Industry Median: 71.44 vs BOM:533543: 85.49

Brooks Laboratories's Days Sales Outstanding declined from Dec. 2022 (94.54) to Mar. 2024 (84.01).


Brooks Laboratories Days Sales Outstanding Historical Data

The historical data trend for Brooks Laboratories's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brooks Laboratories Days Sales Outstanding Chart

Brooks Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.22 69.31 63.53 87.83 66.75

Brooks Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.54 91.66 53.48 66.07 84.01

Competitive Comparison of Brooks Laboratories's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Brooks Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brooks Laboratories's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brooks Laboratories's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Brooks Laboratories's Days Sales Outstanding falls into.



Brooks Laboratories Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Brooks Laboratories's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

Days Sales Outstanding (A: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (127.542 + 163.162) / 2 ) / 794.861*365
=145.352 / 794.861*365
=66.75

Brooks Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (0 + 163.162) / 1 ) / 177.217*365 / 4
=163.162 / 177.217*365 / 4
=84.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brooks Laboratories  (BOM:533543) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Brooks Laboratories Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Brooks Laboratories (BOM:533543) Business Description

Traded in Other Exchanges
Address
Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093
Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. It has manufacturing sites located in Baddi, Himachal Pradesh, and Vadodara, Gujarat. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories (BOM:533543) Headlines

No Headlines